Protein Supplementation of Snakehead Fish Cookies on Pregnant Women

February 9, 2020 updated by: Eugenius Phyowai Ganap, Gadjah Mada University

Protein Supplementation of Snakehead Fish Cookies on Pregnant Women to Prevent Intrauterine Growth Restriction and Low Birth Weight in Sleman District, Yogyakarta Province, Indonesia: a Randomized Controlled Trial Study

This study was randomized controlled trial study whose subjects were pregnant women in Sleman District, Yogyakarta, Indonesia. The aims of this study were to make snakehead fish cookies formula which can be well accepted by pregnant women and to observed its effect on fetal growth and birth weight and length. It was hypothesized that snakehead fish cookies could prevent intrauterine fetal growth (IUGR) and low birth weight (LBW).

Subjects on this study were randomly allocated into two groups which were treatment and control group. Subjects in treatment group were given snakehead fish cookies, while subject in control group received standard cookies. The intervention period lasted until subjects delivered their babies.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Subjects were enrolled from Public Health Center (puskesmas) in Sleman District, Yogyakarta Province, Indonesia. Subjects were being explained about the study intervention and were given informed consent as an approval of joining this study. The intervention was given everyday as much as 75g cookies for several weeks period (until delivery). Examination on fetal growth was done every month for each subjects. Birth weight and length were collected after delivery from child health book record.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Yogyakarta
      • Sleman, Yogyakarta, Indonesia
        • Public Health Center (Puskesmas) in the area of Sleman District

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 25 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  1. second and third trimester gestational age,
  2. lower-class family with income under Sleman District minimum wage in 2019 (< 1,701,000 Rupiah),
  3. pregnant women of under 25 years old, and
  4. high school graduate or below

Exclusion Criteria:

  1. suffering from anemia,
  2. experiencing preeclampsia,
  3. having multiple gestational, and
  4. allergic to fish, eggs, and chocolate.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Snakehead fish cookies
Subjects who were given intervention of snakehead fish cookies during the study period
Either snakehead fish cookies or standard cookies were given to subjects 75g per day.
Placebo Comparator: Standard cookies
Subjects who were in control group and received standard cookies
Either snakehead fish cookies or standard cookies were given to subjects 75g per day.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Estimated fetal weight (EFW)
Time Frame: change from baseline EFW after 1 month
We measured EFW monthly using 2D ultrasonography (USG) for each subjects
change from baseline EFW after 1 month
Biparietal diameter (BPD)
Time Frame: change from baseline BPD after 1 month
We measured BPD monthly using 2D ultrasonography (USG) for each subjects
change from baseline BPD after 1 month
Abdominal circumference (AC)
Time Frame: change from baseline AC after 1 month
We measured AC monthly using 2D ultrasonography (USG) for each subjects
change from baseline AC after 1 month
Femur length (FL)
Time Frame: change from baseline FL after 1 month
We measured FL monthly using 2D ultrasonography (USG) for each subjects
change from baseline FL after 1 month
Birth weight
Time Frame: immediately after the baby is born
Birth weight of the baby
immediately after the baby is born
Birth length
Time Frame: immediately after the baby is born
Birth length of the baby
immediately after the baby is born

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Eugenius P Ganap, PhD, Gadjah Mada University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 3, 2019

Primary Completion (Actual)

December 2, 2019

Study Completion (Actual)

December 2, 2019

Study Registration Dates

First Submitted

February 4, 2020

First Submitted That Met QC Criteria

February 9, 2020

First Posted (Actual)

February 11, 2020

Study Record Updates

Last Update Posted (Actual)

February 11, 2020

Last Update Submitted That Met QC Criteria

February 9, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Snakehead fish cookies

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

This research was supported by Ministry of Health of Indonesia, and all data collected in this study were subject to Indonesian Ministry of Health rights.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy Related

Clinical Trials on cookies

3
Subscribe